Faustini, Gaia <br/><br/>
Synapsin III deficiency hampers α-synuclein aggregation, striatal synaptic damage and nigral cell loss in an AAV-based mouse model of Parkinson's disease.  [electronic resource] 

 -  Acta neuropathologica  10 2018 
 - 621-639 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1432-0533 
<br/><br/><label>Standard No.: </label>10.1007/s00401-018-1892-1  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Amphetamine--pharmacology<br/>Animals<br/>Central Nervous System Stimulants--pharmacology<br/>Dependovirus--genetics<br/>Mice<br/>Mice, Inbred C57BL<br/>Mice, Knockout<br/>Neostriatum--pathology<br/>Nerve Degeneration--genetics<br/>Neurons--pathology<br/>Parkinson Disease--genetics<br/>Stereotyped Behavior--drug effects<br/>Substantia Nigra--pathology<br/>Synapses--pathology<br/>Synapsins--deficiency<br/>Vesicle-Associated Membrane Protein 2--metabolism<br/>alpha-Synuclein--metabolism